IRIS
CAVESTRO, Giulia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.682
AS - Asia 5.502
EU - Europa 4.213
SA - Sud America 731
AF - Africa 306
Continente sconosciuto - Info sul continente non disponibili 69
OC - Oceania 5
Totale 17.508
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.462
SG - Singapore 2.209
CN - Cina 1.505
IT - Italia 803
VN - Vietnam 773
SE - Svezia 650
IE - Irlanda 622
BR - Brasile 546
UA - Ucraina 532
FI - Finlandia 435
DE - Germania 416
HK - Hong Kong 370
TR - Turchia 218
ZA - Sudafrica 210
FR - Francia 183
NL - Olanda 175
CA - Canada 139
GB - Regno Unito 136
BD - Bangladesh 127
RU - Federazione Russa 95
AR - Argentina 78
CI - Costa d'Avorio 54
IN - India 51
MX - Messico 40
IQ - Iraq 33
JP - Giappone 27
BE - Belgio 26
EC - Ecuador 23
PL - Polonia 23
CO - Colombia 20
PH - Filippine 20
AT - Austria 19
LT - Lituania 19
ES - Italia 18
PK - Pakistan 17
UZ - Uzbekistan 17
PE - Perù 14
ID - Indonesia 13
IR - Iran 13
PY - Paraguay 13
TH - Thailandia 13
CL - Cile 12
RO - Romania 12
TW - Taiwan 12
AZ - Azerbaigian 10
VE - Venezuela 10
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
KE - Kenya 8
KR - Corea 8
MA - Marocco 8
TN - Tunisia 8
BO - Bolivia 7
EG - Egitto 7
EU - Europa 7
UY - Uruguay 7
CR - Costa Rica 6
HN - Honduras 6
JO - Giordania 6
PA - Panama 6
GE - Georgia 5
GT - Guatemala 5
IL - Israele 5
JM - Giamaica 5
MY - Malesia 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
HU - Ungheria 4
LB - Libano 4
MD - Moldavia 4
NP - Nepal 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
NO - Norvegia 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 17.426
Salva come PNG Salva come JPEG
Città #
Singapore 1.025
Chandler 859
Ashburn 636
Dublin 619
Jacksonville 539
Santa Clara 519
San Jose 426
Dearborn 401
Hong Kong 353
Beijing 285
Ho Chi Minh City 260
Boardman 259
Nanjing 252
Council Bluffs 228
Johannesburg 200
Izmir 174
Dallas 164
Hanoi 161
Princeton 154
Genoa 153
San Mateo 147
Lauterbourg 137
Ann Arbor 122
Shanghai 115
Tito 114
New York 113
Munich 106
Los Angeles 98
Toronto 89
Shenyang 84
Wilmington 82
Nardò 73
Taranto 73
Helsinki 70
Moscow 68
Nanchang 60
Abidjan 54
São Paulo 54
Hebei 53
Kunming 47
Tianjin 46
Changsha 42
Buffalo 40
Hefei 40
Jiaxing 39
Jinan 39
Da Nang 34
Turku 30
Norwalk 29
Parma 29
Frankfurt am Main 28
Kocaeli 26
Woodbridge 26
Brussels 25
Houston 24
Bari 22
Guangzhou 22
Haiphong 20
Columbus 19
Des Moines 19
Hangzhou 19
Tokyo 19
Zhengzhou 19
Denver 18
Montreal 18
Hải Dương 17
Warsaw 17
Chicago 16
London 16
Orem 16
Phoenix 16
Pune 16
Rome 16
Stockholm 16
Seattle 15
Tashkent 15
Brindisi 14
Rio de Janeiro 14
Tricase 14
Brooklyn 13
Grafing 13
Belo Horizonte 12
Boston 12
Cambridge 12
Ningbo 12
Atlanta 11
Baghdad 11
Brasília 11
Bremen 11
Can Tho 11
Cascina 11
Lima 11
San Gregorio di Catania 11
Nuremberg 10
Porto Alegre 10
Quito 10
San Francisco 10
Surbo 10
Auburn Hills 9
Baku 9
Totale 10.566
Salva come PNG Salva come JPEG
Nome #
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 513
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 450
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 191
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 173
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 167
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 165
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 162
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 160
Natural course of functional dyspepsia after after helicobacter pylori eradication a 7-year survey 159
Association of keratin 8 gene mutation with chronic pancreatitis 159
7 P Frequency of CFTR gene mutations in consecutive patients suffering from chronic pancreatitis 155
Gastro panel® for detection of atrophic gastritis: The “Parma model” 154
Clinical Trends and Burden of Death in Gastric Cancer: A Six Years Survey 154
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 152
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 152
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 151
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 150
Serum pepsinogen II for early assessment of success of H. pylori eradication 150
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 149
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 148
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 145
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 142
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 142
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 141
P.154 CONNECTIONS BETWEEN GENETICS AND CLINICAL DATA: ROLE OF MCP-1, CFTR, AND SPINK-1 IN THE SETTING OF ACUTE, ACUTE RECURRENT, AND CHRONIC PANCREATITIS 140
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 140
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 139
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 139
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 139
Pepsinogen I, II, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-Esophageal Manifestations of GERD 138
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 136
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 136
Low alcohol and cigarette use is associated to the risk of developing chronic pancreatitis 136
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 135
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 135
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 134
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. 134
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) 132
M1141 Diagnostic Accuracy of Serum Pepsinogens and Gastrin to Follow-up Helicobacter pylori Infection: A Pilot Study 131
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 131
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 130
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 130
Usefulness of a serological panel test in the assessment of gastritis in symptomatic children 129
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis 128
A new marker for monitoring alcohol abuse? A pilot study on heavy drinkers 128
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 127
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 126
Italian consensus guideline for chronic pancreatitis. 125
A new curcumin-based one week therapy for eradication of H. pylori infection 122
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 121
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 121
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 120
P.1.292: SYMPTOMATOLOGICAL PATTERN IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD), IRRITABLE BOWEL SYNDROME-DIARRHOEA (IBS-D), AND IBS-D PLUS SUDD 120
PANCREATIC PSEUDOCYSTS FOLLOWING ACUTE PANCREATITIS: RISK FACTORS INFLUENCING THERAPEUTIC OUTCOMES 119
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 118
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium 117
Topography of gastric damage in H.pylori infection: evaluation by serum pepsinogens levels 116
Chronic atrophic gastritis (GAC) and Helicobacter pylori infection eradication: a 3 years follow-up 115
Hypercalcemia due to ectopic secretion of parathyriod related protein from pancreatic carcinoma: a case report 115
P.10 “GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD: PROSPECTIVE SIX MONTHS CLINICAL STUDY 115
Are there useful biomarkers for gastric cancer? 113
Study design biases in pancreatic inflammatory diseases. 112
DO PREBIOTICS RELIEVE CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) SYMPTOMS? A RANDOMIZED SINGLE BLINDED STUDY 112
Clinical and radiological outcome of patients suffering from chronic pancreatitis associated with gene mutations. 112
CORRELATION BETWEEN LACTOSE H2-BREATH TEST AND CLINICAL DATA: IS IT POSSIBLE TO SELECT PATIENTS WHO NEED LACTOSE BREATH TEST? 110
Recovery of gastric function after H. pylori eradication in subjects with body atrophic gastritis: a prospective four years study 110
Quality of life in patients with chronic pancreatitis 109
Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update 109
Efficacy of mesalazine in the treatment of symptomatic diverticular disease 108
Lactoferrin: mechanism of action, clinical significance and therapeutic 107
Usefullness of gastropanel in different topography of H. pylori related chronic gastritis 106
Assessment of H. pylori-related chronic gastritis by means of serum pepsinogens and oral sucrose 106
Gastroprotective effects of Amtolmetin Guacyl: a new non steroidal antiinflammatory drug that activates inducible gastric niytric oxide synthase 105
Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. 105
Prevalence of H. pylori CagA+ve in suburban area with high incidence of gastric cancer 104
Imaging of a small bowel cavernous hemangioma: report of a case with emphasis on the use of computed tomography and enteroclysis. 104
P.1.325: USEFULNESS OF SERUM PEPSINOGENS TO IDENTIFY CHRONIC ATROP H IC GASTRITIS 103
“The yellow stomach“: clinical relevance in endoscopical series 101
Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study 100
Nonteroidal drug-related gastroduodenal damage in the elderly 99
Rabeprazole in the treatment of non-responders GERD patients: a prospective six-month study 99
TAP genes, coding for the transporters associated with antigen processing, contribute to the genetic predisposition to primary sclerosing cholangitis (PSC) 99
Ursodeoxycholic acid Vs cisapride in the treatment of duodenogastric reflux 99
Rabeprazole for the treatment of oropharingeal picture of GERD: a six-month prospective study 98
THE SIZE OF PANCREATIC PSEUDOCYST DOES NOT INFLUENCE THE OUTCOME OF INVASIVE TREATMENTS 98
Hyperbilirubinemia: does it matter? 98
Therapy of NERD: single Vs double rabeprazole dosage 97
Macrohematuria caused by a fall in prothrombin activity as a clinical presentation of celiac disease. (I.F. 1.357) 97
HLA-DRB1*04 Allele contribute to the genetic susceptibility of chronic pancreatitis 97
Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels 96
Gastropanel as screening of gastric atrophy in primary care 96
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 96
Serum pepsinogen II as a biomarker in management of H. pylori infection 96
Clinical usefulness of Gastropanel (SPGI, SPGII, GASTRIN-17, HP SPECIFIC IgG) in the assessment of HP infection 95
Lactoferrin in a one week triple therapy for eradication of H. Pylori 95
Diagnosis of H. pylori gastritis patterns by means of gastropanel 95
Relationship between direct and indirect methods for diagnosis of H.pylori infection 95
‘Serological Biopsy’ in first degree relatives of patients with gastric cancer, affected by Helicobacter pylori 95
Early epigastric pain after PPI administration: exacerbation of Helicobacter pyolori corpus gastritis? 95
Serum pepsinogen II and Gastrin-17 (G-17) as markers of NSAIDS gastropathy 94
Totale 13.066
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.807
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022763 0 15 10 36 43 17 80 108 32 87 92 243
2022/20232.618 294 253 169 234 238 325 7 188 797 9 81 23
2023/2024784 53 84 24 22 56 217 40 61 18 48 77 84
2024/20253.030 83 187 214 148 364 356 36 142 452 286 219 543
2025/20266.038 515 523 519 542 853 442 640 168 858 519 289 170
2026/2027433 188 245 0 0 0 0 0 0 0 0 0 0
Totale 17.508